1	European Monitoring Centre for Drugs and Drug Addiction. (2017) European drug report: trends and developments. 2017. http://www.emcdda.europa.eu/system/files/publications/4541/TDAT17001ENN.pdf (accessed August 7, 2018).
2	Santé Canada. (2018) Rapport national: Décès apparemment liés à la consommation d’opioïdes au Canada (juin 2018). https://www.canada.ca/fr/sante-publique/services/publications/vie-saine/rapport-national-deces-apparemment-lies-consommation-opioides-publie-juin-2018.html (accessed July 19, 2018).
3	Lucyk, S.N., Nelson, L.S. (2017) Novel synthetic opioids: an opioid epidemic within an opioid epidemic. Annals of Emergency Medicine , 69, 91–93.
4	Seth, P., Scholl, L., Rudd, R.A., Bacon, S. (2018) Overdose deaths involving opioids, cocaine, and psychostimulants—United States, 2015–2016. Morbidity and Mortality Weekly Report , 67, 349–358.
5	Dart, R.C., Surratt, H.L., Cicero, T.J., Parrino, M.W., Severtson, S.G., Bucher-Bartelson, B., et al. . (2015) Trends in opioid analgesic abuse and mortality in the United States. New England Journal of Medicine , 372, 241–248.
6	Canadian Institute of Health Information. (2017) Pan-Canadian Trends in the Prescribing of Opioids, 2012 to 2016. Ottawa, ON. https://www.cihi.ca/sites/default/files/document/pan-canadian-trends-opioid-prescribing-2017-en-web.pdf (accessed August 7, 2018).
7	Brandt, S.D., King, L.A., Evans-Brown, M. (2014) The new drug phenomenon. Drug Testing and Analysis , 6, 587–597.
8	Hibbs, J., Perper, J., Winek, C.L. (1991) An outbreak of designer drug—related deaths in pennsylvania. JAMA : The Journal of the American Medical Association , 265, 1011–1013.
9	Henderson, G.L. (1988) Designer drugs: past history and future prospects. Journal of Forensic Sciences , 33, 569–575.
10	United Nation Office on Drugs and Crime. (2017) World Drug Report 2017. https://www.unodc.org/wdr2017/index.html (accessed July 19, 2018).
11	Shoff, E.N., Zaney, M.E., Kahl, J.H., Hime, G.W., Boland, D.M. (2017) Qualitative identification of fentanyl analogs and other opioids in postmortem cases by UHPLC-ion Trap-MSn. Journal of Analytical Toxicology , 41, 484–492.
12	Wang, L., Bernert, J.T. (2006) Analysis of 13 fentanils, including sufentanil and carfentanil, in human urine by liquid chromatography-atmospheric-pressure ionization-tandem mass spectrometry*. Journal of Analytical Toxicology , 30, 335–341.
13	Côté, C., Desharnais, B., Morel, M.-A., Laquerre, J., Taillon, M.-P., Daigneault, G., et al. . (2017) High Throughput Protein Precipitation: Screening and Quantification of 106 Drugs and their metabolites using LC-MS/MS. SOFT-TIAFT 2017, Boca Raton, Fl, USA.
14	Scientific Working Group for Forensic Toxicology. (2013) Scientific Working Group for Forensic Toxicology (SWGTOX) standard practices for method validation in forensic toxicology. Journal of Analytical Toxicology , 37, 452–474.
15	NMS Labs, Designer Opioids (2018 Scope) Blood Test (1480B). http://www.nmslabs.com/tests/Designer-Opioids--2018-Scope---Blood/1480B (accessed November 19, 2018)
16	Kacinko, S.L., Homan, J.W. Quantification of designer opioids by liquid chromatography–tandem mass spectrometry. In: Langman, L.J., Snozek, C.L.H. (eds). LC-MS in Drug Analysis: Methods and Protocols . Springer: New York, New York, NY, 2019; pp. 149–163. https://doi.org/10.1007/978-1-4939-8823-5_15.
17	Watanabe, S., Vikingsson, S., Roman, M., Green, H., Kronstrand, R., Wohlfarth, A. (2017) In vitro and in vivo metabolite identification studies for the new synthetic opioids acetylfentanyl, acrylfentanyl, furanylfentanyl, and 4-fluoro-isobutyrylfentanyl. The AAPS Journal , 19, 1102–1122.
18	Goromaru, T., Matsuura, H., Yoshimura, N., Miyawaki, T., Sameshima, T., Miyao, J., et al. . (1984) Identification and quantitative determination of fentanyl metabolites in patients by gas chromatography–mass spectrometry. Anesthesiology , 61, 73–77.
19	National Institute on Drug of Abuse. (2018) Opioid summaries by state. National Institute on Drug of Abuse, February 2018. https://www.drugabuse.gov/drugs-abuse/opioids/opioid-summaries-by-state (accessed July 19, 2018).
20	Belzak, L., Halverson, J. (2018) Evidence synthesis—the opioid crisis in Canada: a national perspective. Health Promotion and Chronic Disease Prevention in Canada , 38, 224–233.
21	Viel, É., Mireault, P. (2015) Tracking New Drug Trends in Quebec from Drug Seizures to Impaired Drivers and Programm Review of Canada’s Drug Impaired Law. Drugs & Driving Symposium, June 2015.
22	Laboratory and Scientific Section. (2017) Recommended methods for the identification and analysis of fentanyl and its analogues in biological specimens. UNITED NATIONS OFFICE ON DRUGS AND CRIME, Vienne. http://www.unodc.org/documents/scientific/Recommended_methods_for_the_identification_and_analysis_of_Fentanyl.pdf (accessed July 19, 2018)
23	Chindarkar, N.S., Park, H.-D., Stone, J.A., Fitzgerald, R.L. (2015) Comparison of different time of flight-mass spectrometry modes for small molecule quantitative analysis. Journal of Analytical Toxicology , 39, 675–685.
24	Andeason, M.F., Hardlei, T.F., Rosendal, I., Hedegaard Thomsen, A., Johannsen, M., Saedder, E. (2018) A Fatal Poisoning Involving 2-fluorofentanyl, SOFT-TIAFT 2017, Boca Raton, Fl, USA.
25	Yong, H.L., Frost, K., Harper, C.E. (2018) Non-pharmaneuticals Fentanyls Encountered by the Alabama Departement of Forensic Sciences. SOFT-TIAFT 2017, Boca Raton, Fl, USA.
26	Swanson, D.M., Hair, L.S., Strauch Rivers, S.R., Smyth, B.C., Brogan, S.C., Ventoso, A.D., et al. . (2017) Fatalities involving carfentanil and furanyl fentanyl: two case reports. Journal of Analytical Toxicology , 41, 498–502.
27	Krotulski, A.J., Papsun, D.M., Friscia, M., Swartz, J.L., Holsey, B.D., Logan, B.K. (2018) Fatality following ingestion of tetrahydrofuranylfentanyl, U-49900 and methoxy-phencyclidine. Journal of Analytical Toxicology , 42, e27–e32.
28	Miller, A.M., Janis, G.C., Goggin, M.M. (2018) Anodyne by Design; Detecting Designer Opioids in Pain Management. SOFT-TIAFT 2017, Boca Raton, Fl, USA.
29	Bäckberg, M., Beck, O., Jönsson, K.-H., Helander, A. (2015) Opioid intoxications involving butyrfentanyl, 4-fluorobutyrfentanyl, and fentanyl from the Swedish STRIDA project. Clinical Toxicology , 53, 609–617.
30	Mohr, A.L.A., Friscia, M., Papsun, D., Kacinko, S.L., Buzby, D., Logan, B.K. (2016) Analysis of novel synthetic opioids U-47700, U-50488 and furanyl fentanyl by LC–MS/MS in postmortem casework. Journal of Analytical Toxicology , 40, 709–717.
31	Martucci, H.F.H., Ingle, E.A., Hunter, M.D., Rodda, L.N. (2018) Distribution of furanyl fentanyl and 4-ANPP in an accidental acute death: a case report. Forensic Science International , 283, e13–e17.
32	Prekupec, M.P., Mansky, P.A., Baumann, M.H. (2017) Misuse of novel synthetic opioids: a deadly new trend. Journal of Addiction Medicine , 11, 256–265.
33	Armenian, P., Vo, K.T., Barr-Walker, J., Lynch, K.L. (2017) Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review. Neuropharmacology , 134, 121–132.
34	Suzuki, J., El-Haddad, S. (2017) A review: fentanyl and non-pharmaceutical fentanyls. Drug and Alcohol Dependence , 171, 107–116.